Treatment of breast cancer during pregnancy

Expert Opinion on Pharmacotherapy
Harold J BursteinBeth-Ann Lesnikoski

Abstract

The management of breast cancer during pregnancy is one of the great clinical challenges in oncology. Patients are best served by care provided through a multidisciplinary team including surgeons, oncologists, obstetricians and genetics counsellors with experience in caring for similar women. The risks of diagnostic and therapeutic interventions can be mitigated by the consideration of known side effects of therapy on the fetus and the mother. However, because of the limited amount of clinical experience available, the potential risks to the patient, to the fetus and to the pregnancy are difficult to quantify. Treatment decisions need to be tailored carefully to the individual, respecting both her clinical circumstances and her personal preferences.

References

Jul 1, 1978·International Journal of Radiation Oncology, Biology, Physics·R M Clark, J Reid
Mar 1, 1992·Archives of Internal Medicine·D ZemlickisG Koren
Mar 1, 1992·American Journal of Obstetrics and Gynecology·D ZemlickisG Koren
Feb 15, 1991·Cancer·J A PetrekA Rogatko
Nov 1, 1989·American Journal of Obstetrics and Gynecology·R I Mazze, B Källén
Feb 1, 1988·Cancer·J J Turchi, C Villasis
Aug 1, 1986·The British Journal of Surgery·G RibeiroM Jones
Nov 1, 1985·Archives of Surgery·P Nugent, T X O'Connell
Mar 1, 1983·Current Problems in Cancer·M K WallackS Wilson-Krechel
Jul 1, 1994·Cancer·J A Petrek
Apr 1, 1994·Critical Reviews in Oncology/hematology·V J Wiebe, P E Sipila
Oct 2, 1993·Lancet·P Vancutsem, G M Williams
Apr 1, 1994·Radiology·L LibermanJ A Petrek
Nov 1, 1993·AJR. American Journal of Roentgenology·E M SchackmuthL W Norton
Sep 17, 1996·International Journal of Cancer. Journal International Du Cancer·A E LethabyV J Harvey
Jul 19, 1997·Lancet·K TewariA M Shanberg
Jan 1, 1997·Pharmacology & Therapeutics·U EbertW Kirch
Oct 1, 1998·The New England Journal of Medicine·G N Hortobagyi
Mar 10, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L BerryG N Hortobagyi
Nov 26, 1999·The Surgical Clinics of North America·M L GemignaniP I Borgen

❮ Previous
Next ❯

Citations

Feb 22, 2003·Current Treatment Options in Oncology·Hope S Rugo
May 29, 2015·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Oihana PascualMaria-Reyes Abad
Nov 3, 2005·Nature Clinical Practice. Oncology·Matthew S KatzKevin S Hughes
Jan 20, 2012·Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association·V ValentiniG E Martorana
Apr 28, 2012·CA: a Cancer Journal for Clinicians·Cheryl L RockTed Gansler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Seminars in Surgical Oncology
Jeanne A. Petrek
Obstetrics and Gynecology Clinics of North America
Stephen S Falkenberry
European Journal of Obstetrics, Gynecology, and Reproductive Biology
C GiannakopoulouE Koumandakis
The Breast Journal
Mary L. Gemignani, Jeanne A. Petrek
© 2022 Meta ULC. All rights reserved